{"id":"https://openalex.org/W2802523429","doi":"https://doi.org/10.1007/s13300-018-0424-2","title":"A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1\u20132 Oral Anti-Diabetic Drugs","display_name":"A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1\u20132 Oral Anti-Diabetic Drugs","alternate_titles":[],"publication_year":2018,"publication_date":"2018-04-19","ids":{"openalex":"https://openalex.org/W2802523429","doi":"https://doi.org/10.1007/s13300-018-0424-2","mag":"2802523429","pmid":"https://pubmed.ncbi.nlm.nih.gov/29675798","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5984927"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-018-0424-2","doi":"https://doi.org/10.1007/s13300-018-0424-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-018-0424-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-018-0424-2.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2802523429"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-018-0424-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017995543","display_name":"Micha\u0142 Witkowski","orcid":"https://orcid.org/0000-0001-9845-6214","observed_orcids":["https://orcid.org/0000-0001-9845-6214"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michal Witkowski","raw_affiliation_strings":["DRG Abacus, Bicester, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DRG Abacus, Bicester, Oxfordshire, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026271428","display_name":"Lars Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Wilkinson","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102884938","display_name":"Neil Webb","orcid":"https://orcid.org/0000-0003-1062-5752","observed_orcids":["https://orcid.org/0000-0003-1062-5752"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Neil Webb","raw_affiliation_strings":["DRG Abacus, Bicester, Oxfordshire, UK. nwebb@teamdrg.com","DRG Abacus, Bicester, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DRG Abacus, Bicester, Oxfordshire, UK. nwebb@teamdrg.com","institution_ids":[]},{"raw_affiliation_string":"DRG Abacus, Bicester, Oxfordshire, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042145908","display_name":"Alan Weids","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan Weids","raw_affiliation_strings":["DRG Abacus, Bicester, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DRG Abacus, Bicester, Oxfordshire, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001956790","display_name":"Divina R Glah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126084","display_name":"Novo Nordisk (United Kingdom)","ror":"https://ror.org/0415cr103","country_code":"GB","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210126084","https://openalex.org/I4210159963"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Divina Glah","raw_affiliation_strings":["Novo Nordisk Ltd, Gatwick, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Ltd, Gatwick, UK","institution_ids":["https://openalex.org/I4210126084"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054552742","display_name":"Hrvoje Vra\u017ei\u0107","orcid":"https://orcid.org/0000-0001-8151-9899","observed_orcids":["https://orcid.org/0000-0001-8151-9899"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hrvoje Vrazic","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":"https://orcid.org/0000-0001-8151-9899","affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102884938"],"corresponding_institution_ids":[],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":0.866,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.65316168,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"9","issue":"3","first_page":"1149","last_page":"1167"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9089999794960022},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9810000061988831},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7870000004768372},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6320000290870667},{"id":"https://openalex.org/keywords/systolic-blood-pressure","display_name":"systolic blood pressure","score":0.7950000166893005},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6840000152587891},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9933083653450012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.895516037940979},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6186991930007935},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5524159073829651},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5286434292793274},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5051196217536926},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4982616901397705},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.497800350189209},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48950326442718506},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.4835088551044464},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46462756395339966},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.38602542877197266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36693525314331055},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.2822989821434021},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24896776676177979},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08097323775291443},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13300-018-0424-2","doi":"https://doi.org/10.1007/s13300-018-0424-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-018-0424-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-018-0424-2.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4950656","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5984927","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5984927","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5984927/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmid:29675798","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29675798","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s13300-018-0424-2","doi":"https://doi.org/10.1007/s13300-018-0424-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-018-0424-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-018-0424-2.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2802523429.pdf","grobid_xml":"https://content.openalex.org/works/W2802523429.grobid-xml"},"referenced_works_count":84,"referenced_works":["https://openalex.org/W194160568","https://openalex.org/W580477814","https://openalex.org/W952614140","https://openalex.org/W1482710124","https://openalex.org/W1500626787","https://openalex.org/W1504183466","https://openalex.org/W1505367831","https://openalex.org/W1598602811","https://openalex.org/W1883583237","https://openalex.org/W1923756566","https://openalex.org/W1924318177","https://openalex.org/W1945841307","https://openalex.org/W1969151129","https://openalex.org/W1971474519","https://openalex.org/W1971796502","https://openalex.org/W1975929001","https://openalex.org/W1983483428","https://openalex.org/W1984740259","https://openalex.org/W1989713397","https://openalex.org/W2003415509","https://openalex.org/W2007221722","https://openalex.org/W2010699829","https://openalex.org/W2010976066","https://openalex.org/W2014554878","https://openalex.org/W2019513002","https://openalex.org/W2023984564","https://openalex.org/W2036532013","https://openalex.org/W2040767736","https://openalex.org/W2054981500","https://openalex.org/W2060976026","https://openalex.org/W2062098402","https://openalex.org/W2066046508","https://openalex.org/W2067533175","https://openalex.org/W2077751509","https://openalex.org/W2097771449","https://openalex.org/W2099352903","https://openalex.org/W2107949845","https://openalex.org/W2108430483","https://openalex.org/W2113367996","https://openalex.org/W2123946565","https://openalex.org/W2127622911","https://openalex.org/W2133648480","https://openalex.org/W2135918169","https://openalex.org/W2138749579","https://openalex.org/W2148754755","https://openalex.org/W2150453599","https://openalex.org/W2152984355","https://openalex.org/W2154433510","https://openalex.org/W2156098321","https://openalex.org/W2157494695","https://openalex.org/W2160001758","https://openalex.org/W2160088494","https://openalex.org/W2170606300","https://openalex.org/W2184899074","https://openalex.org/W2193379135","https://openalex.org/W2199333711","https://openalex.org/W2276028032","https://openalex.org/W2341996933","https://openalex.org/W2443999297","https://openalex.org/W2463959854","https://openalex.org/W2496180703","https://openalex.org/W2509949587","https://openalex.org/W2511827836","https://openalex.org/W2514766623","https://openalex.org/W2519510391","https://openalex.org/W2524961794","https://openalex.org/W2551448889","https://openalex.org/W2572398654","https://openalex.org/W2602700371","https://openalex.org/W2604152120","https://openalex.org/W2604469807","https://openalex.org/W2616379431","https://openalex.org/W2763255780","https://openalex.org/W2769264260","https://openalex.org/W2774157762","https://openalex.org/W2787255324","https://openalex.org/W2789732774","https://openalex.org/W2916996193","https://openalex.org/W2991792334","https://openalex.org/W3171237122","https://openalex.org/W4205636518","https://openalex.org/W4213412326","https://openalex.org/W4240794548","https://openalex.org/W4254014359"],"related_works":["https://openalex.org/W2799276912","https://openalex.org/W2979451288","https://openalex.org/W3137323645","https://openalex.org/W2793578368","https://openalex.org/W2963090082","https://openalex.org/W2784318050","https://openalex.org/W2809169680","https://openalex.org/W7165679173","https://openalex.org/W1950437517","https://openalex.org/W2804862484"],"abstract_inverted_index":{"Once-weekly":[0,167,187],"semaglutide":[1,22,59,168,188,213,231,270],"is":[2,240,271],"a":[3,11,41,114,150,153],"new":[4],"glucagon-like":[5],"peptide-1":[6],"(GLP-1)":[7],"analogue":[8],"administered":[9],"at":[10,98],"1.0":[12,169,232],"or":[13],"0.5":[14,189],"mg":[15,170,190,233],"dose.":[16],"As":[17],"head-to-head":[18],"trials":[19,86],"assessing":[20],"once-weekly":[21,58,212,230,269],"as":[23,137,139,234],"an":[24,235,278],"add-on":[25,236],"to":[26,50,84,142,222,237,283],"1\u20132":[27,73,95,238],"oral":[28],"anti-diabetic":[29],"drugs":[30],"(OADs)":[31],"vs":[32,60,182],"other":[33,206,226,287],"GLP-1":[34,61,88,184,207,227,244,288],"receptor":[35],"agonists":[36],"(GLP-1":[37],"RAs)":[38],"are":[39],"limited,":[40],"network":[42],"meta-analysis":[43],"(NMA)":[44],"was":[45,49,80,171],"performed.":[46],"The":[47],"objective":[48],"assess":[51],"the":[52,118,163,203,241,249,265],"relative":[53],"efficacy":[54,106],"and":[55,107,135,152,180,199,254,274],"safety":[56,108],"of":[57,87,121,205,211,219,248,251,261],"RAs":[62,89],"in":[63,82,90,113,125,177,196,246,280],"patients":[64,91],"with":[65,173,202,216,225,277,286],"type":[66],"2":[67],"diabetes":[68],"(T2D)":[69],"inadequately":[70,92],"controlled":[71,93],"on":[72,94],"OADs.":[74,96],"A":[75],"systematic":[76],"literature":[77],"review":[78],"(SLR)":[79],"conducted":[81],"order":[83],"identify":[85],"Data":[97,146],"24":[99],"\u00b1":[100],"4":[101],"weeks":[102],"were":[103,147,160,214],"extracted":[104],"for":[105,111],"outcomes":[109,120],"(feasible":[110],"analysis":[112,266],"NMA),":[115],"which":[116],"included":[117,161],"key":[119],"change":[122],"from":[123,256],"baseline":[124,257],"glycated":[126],"hemoglobin":[127],"(HbA":[128],"1c":[129,179,198,253],"),":[130],"systolic":[131],"blood":[132],"pressure":[133],"(SBP),":[134],"weight,":[136],"well":[138,272],"discontinuation":[140,220],"due":[141,221,282],"adverse":[143],"events":[144],"(AEs).":[145],"synthesized":[148],"using":[149],"NMA":[151],"Bayesian":[154],"framework.":[155],"In":[156,263],"total,":[157],"26":[158],"studies":[159],"across":[162],"base":[164],"case":[165],"analyses.":[166],"associated":[172,215,276],"significantly":[174,193],"greater":[175,194],"reductions":[176,195],"HbA":[178,197,252],"weight":[181,200,255],"all":[183],"RA":[185,245],"comparators.":[186],"also":[191],"achieved":[192],"compared":[201,224,285],"majority":[204],"RAs.":[208,228,289],"Both":[209],"doses":[210],"similar":[217],"odds":[218],"AEs":[223,284],"Overall,":[229],"OADs":[239],"most":[242],"efficacious":[243],"terms":[247],"reduction":[250],"after":[258],"6":[259],"months":[260],"treatment.":[262],"addition,":[264],"suggests":[267],"that":[268],"tolerated":[273],"not":[275],"increase":[279],"discontinuations":[281],"Novo":[290],"Nordisk.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2802523429","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-05-17T00:00:00"}
